接受静脉-静脉体外膜氧合治疗的2019冠状病毒病患者的脑自动调节、脑血流动力学与损伤生物标志物
单中心观察性研究纳入2020年10月至2022年2月弗罗茨瓦夫大学医院ICU的16例COVID-19相关ARDS接受静脉-静脉体外膜氧合治疗患者,用经颅多普勒记录大脑中动脉至少20分钟,以平均流速指数(Mxa)评估脑自动调节,Mxa阳性定义为脑自动调节受损,同步采血测神经元特异性烯醇化酶(NSE)。12例存在脑自动调节受损,7例死亡者中6例脑自动调节受损;Mxa阳性预测死亡的灵敏度为85.7%。NSE预测死亡的截断值为28.9 µg/L(曲线下面积=0.83,p=0.006),NSE升高与脑自动调节受损强相关(χ2=6.24;p=0.035;φ=0.69)。作者认为这一初步分析提示该人群应考虑先进神经监测与生物标志物评估。
要点
- 16例COVID-19相关ARDS行VV-ECMO患者中12例脑自动调节受损,7例死亡者中6例脑自动调节受损。
- Mxa阳性是死亡的显著预测因子,灵敏度85.7%。
- NSE预测死亡的截断值为28.9 µg/L,曲线下面积=0.83,p=0.006。
- NSE升高与脑自动调节受损强相关:χ2=6.24;p=0.035;φ=0.69。
- 作者认为该人群应考虑先进神经监测与生物标志物评估(初步分析)。
适用人群与场景
- 单中心ICU中确诊COVID-19并急性呼吸窘迫综合征、正在接受静脉-静脉体外膜氧合治疗的患者;16例符合纳入标准并入选,中位年龄39(34-56)岁。
诊断标准与关键阈值
- 脑自动调节以平均流速指数(Mxa)评估,即脑血流速度慢波振荡与动脉血压之间的移动相关系数;脑自动调节受损定义为Mxa阳性。
- 经颅多普勒记录大脑中动脉至少20分钟;NSE血样与经颅多普勒测量同时采集。
- NSE预测死亡的截断值为28.9 µg/L。
红旗征与不能漏的情况
- Mxa阳性提示脑自动调节受损,是死亡的显著预测因子(灵敏度85.7%),7例死亡者中6例存在脑自动调节受损。
研究设计与关键结果
- 单中心观察性研究,2020年10月至2022年2月在弗罗茨瓦夫大学医院ICU开展,16例COVID-19相关ARDS行静脉-静脉体外膜氧合治疗患者入选,中位年龄39(34-56)岁。
- 12例发现脑自动调节受损;7例死亡患者中6例脑自动调节受损;Mxa阳性是死亡的显著预测因子,灵敏度85.7%。
- 5例脑计算机断层扫描有病理性改变的患者中3例、10例有神经系统并发症的患者中6例存在脑自动调节受损。
- NSE是死亡的显著预测因子(截断值28.9 µg/L;曲线下面积=0.83,p=0.006),NSE升高与脑自动调节受损强相关(χ2=6.24;p=0.035;φ=0.69)。
证据类型、等级与局限
- 证据类型:单中心观察性研究(原文为单中心、观察性研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对于COVID-19相关ARDS需静脉-静脉体外膜氧合治疗的患者,应考虑先进神经监测与NSE等生物标志物评估;原文将其定位为初步分析。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: This study aimed to describe the cerebrovascular dynamics, in particular cerebral autoregulation (CA), and cerebral biomarkers as neuron-specific enolase (NSE) in patients with a diagnosis of coronavirus disease 2019 and acute respiratory distress syndrome as well as undergoing veno-venous extracorporeal membrane treatment.
METHODS: This was a single center, observational study conducted in the intensive care unit of the University Hospital in Wroclaw from October 2020 to February 2022. Transcranial Doppler recordings of the middle cerebral artery conducted for at least 20 min were performed. Cerebral autoregulation (CA) was estimated by using the mean velocity index (Mxa), calculated as the moving correlation coefficient between slow-wave oscillations in cerebral blood flow velocity and arterial blood pressure. Altered CA was defined as a positive Mxa. Blood samples for the measurement of NSE were obtained at the same time as transcranial Doppler measurements.
RESULTS: A total of 16 patients fulfilled the inclusion criteria and were enrolled in the study. The median age was 39 (34-56) years. Altered CA was found in 12 patients, and six out of seven patients who died had altered CA. A positive Mxa was a significant predictor of mortality, with a sensitivity of 85.7%. We found that three out of five patients with pathological changes in brain computed tomography and six out of ten patients with neurological complications had altered CA. NSE was a significant predictor of mortality (cutoff value: 28.9 µg/L); area under the curve = 0.83, p = 0.006), with a strong relationship between increased level of NSE and altered CA, χ2 = 6.24; p = 0.035; φ = 0.69.
CONCLUSIONS: Patients with coronavirus disease 2019-related acute respiratory distress syndrome, requiring veno-venous extracorporeal membrane treatment, are likely to have elevated NSE levels and altered CA. The CA was associated with NSE values in this group. This preliminary analysis suggests that advanced neuromonitoring and evaluation of biomarkers should be considered in this population.
参考来源
- Burzyńska M, Uryga A, Kasprowicz M, et al. Cerebral Autoregulation, Cerebral Hemodynamics, and Injury Biomarkers, in Patients with COVID-19 Treated with Veno-Venous Extracorporeal Membrane Oxygenation. Neurocrit Care. 2023. PMID: 36949359. doi:10.1007/s12028-023-01700-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。